Stock Scorecard
Stock Summary for Neuronetics Inc (STIM) - $2.90 as of 10/29/2025 9:19:24 PM EST
Total Score
5 out of 30
Safety Score
23 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for STIM
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for STIM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for STIM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for STIM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for STIM (23 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for STIM
Financial Details for STIM
Company Overview |
|
|---|---|
| Ticker | STIM |
| Company Name | Neuronetics Inc |
| Country | USA |
| Description | Neuronetics, Inc. (STIM) is a commercial-stage medical technology company specializing in innovating and marketing non-invasive therapeutic solutions for psychiatric disorders, with a strong emphasis on major depressive disorder and obsessive-compulsive disorder. Headquartered in Malvern, Pennsylvania, Neuronetics leverages its proprietary neurostimulation technology to offer effective treatment options, targeting the growing demand for advanced mental health therapies. With a commitment to improving patient outcomes, the company is well-positioned in the evolving landscape of mental health care both in the U.S. and globally. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 2.90 |
| Price 4 Years Ago | 4.46 |
| Last Day Price Updated | 10/29/2025 9:19:24 PM EST |
| Last Day Volume | 784,529 |
| Average Daily Volume | 1,102,622 |
| 52-Week High | 5.92 |
| 52-Week Low | 0.52 |
| Last Price to 52 Week Low | 457.69% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.03 |
| Sector PE | 40.93 |
| 5-Year Average PE | -4.05 |
| Free Cash Flow Ratio | 17.06 |
| Industry Free Cash Flow Ratio | 35.31 |
| Sector Free Cash Flow Ratio | 29.03 |
| Current Ratio Most Recent Quarter | 2.02 |
| Total Cash Per Share | 0.17 |
| Book Value Per Share Most Recent Quarter | 0.41 |
| Price to Book Ratio | 6.50 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.16 |
| Price to Sales Ratio Twelve Trailing Months | 1.86 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.62 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.96 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 66,125,000 |
| Market Capitalization | 191,762,500 |
| Institutional Ownership | 59.01% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -44.78% |
| Reported EPS 12 Trailing Months | -1.14 |
| Reported EPS Past Year | -0.36 |
| Reported EPS Prior Year | -1.37 |
| Net Income Twelve Trailing Months | -48,294,000 |
| Net Income Past Year | -43,708,000 |
| Net Income Prior Year | -30,189,000 |
| Quarterly Revenue Growth YOY | 131.70% |
| 5-Year Revenue Growth | 3.63% |
| Operating Margin Twelve Trailing Months | -21.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 10,969,000 |
| Total Cash Past Year | 18,459,000 |
| Total Cash Prior Year | 59,677,000 |
| Net Cash Position Most Recent Quarter | -44,570,000 |
| Net Cash Position Past Year | -36,692,000 |
| Long Term Debt Past Year | 55,151,000 |
| Long Term Debt Prior Year | 59,283,000 |
| Total Debt Most Recent Quarter | 55,539,000 |
| Equity to Debt Ratio Past Year | 0.33 |
| Equity to Debt Ratio Most Recent Quarter | 0.33 |
| Total Stockholder Equity Past Year | 27,706,000 |
| Total Stockholder Equity Prior Year | 34,190,000 |
| Total Stockholder Equity Most Recent Quarter | 27,147,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -35,456,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.54 |
| Free Cash Flow Past Year | -32,463,000 |
| Free Cash Flow Prior Year | -34,407,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.08 |
| MACD Signal | -0.10 |
| 20-Day Bollinger Lower Band | 2.34 |
| 20-Day Bollinger Middle Band | 3.38 |
| 20-Day Bollinger Upper Band | 4.42 |
| Beta | 1.17 |
| RSI | 42.75 |
| 50-Day SMA | 3.21 |
| 150-Day SMA | 2.88 |
| 200-Day SMA | 3.04 |
System |
|
| Modified | 10/28/2025 10:28:27 AM EST |